The effect of ajwain, viper’s bugloss and cinnamon product on multiple sclerosis patients

The effect of ajwain, viper’s bugloss and cinnamon product on liver function and quality of life of multiple sclerosis patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190120042424N1

Enrollment

Registered

2019-06-24

Start date

2018-10-23

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MULTIPLE SCLEROSIS. Multiple sclerosis

Interventions

Intervention 1: Intervention group: drug, distilled product of ajwain, cinnamon and borago. twice a day, each time 15 cc. Intervention 2: Control group: placebo, twice a day, each time 15 cc.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: proved MS disease according to clinical examination and patient history EDSS score between 2-5.5 regular and fix drug therapy in last 4 week

Exclusion criteria

Exclusion criteria: drug or alcohol abuse history pregnancy and lactation in last 12 months kidney and liver dysfunction steroid therapy 2 months before study

Design outcomes

Primary

Measure	Time frame
Liver function. Timepoint: study start, 3 months after taking drug. Method of measurement: laboratory exam.;Quality of life. Timepoint: study start, 3 months after taking drug. Method of measurement: MSQOL-54 questionaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactrahil ghanavati

Ahvaz University of Medical Sciences

rahil_ghanavati@yahoo.com+98 61 3414 4664

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026